Maiwald is one of Germany’s largest and best-known IP firms, with more than 280 staff members across its offices in Munich and Düsseldorf. Its interdisciplinary teams, comprising more than 110 patent attorneys, attorneys-at-law and technical specialists including an in-house patent search department, advise clients of every size and sector, in Germany, Europe and beyond.
The firm’s technical breadth is exceptional, running from pharmaceuticals, biotechnology and chemistry, which have long been a particular strength, through to electrical and mechanical engineering, communications and IT, mobility and energy, and medical technology.
Maiwald’s work spans the full patent lifecycle, from drafting and worldwide prosecution to FTO opinions and complex portfolio management, alongside a leading contentious practice: opposition and appeal before the German and European Patent Offices, infringement and nullity before the national courts, and representation before the Unified Patent Court, with attorneys-at-law experienced in coordinating cross-border litigation. The firm is consistently ranked by IAM Patent 1000, MIP IP Stars, Chambers, JUVE Patent and The Legal 500. They are also voted one of the best commercial law firms by brandeins and Statista.
The bar at Maiwald is high. A technically demanding docket, complex multi-jurisdictional disputes, and a quality standard maintained for decades meant that any AI platform had to prove it could meet the firm where it works.
Maiwald conducted an evaluation period during which various functionalities were assessed for selected internal use cases.
The key to a successful evaluation and implementation requires the level of organisation and teamwork that Maiwald is known for and a solution that enhances the commercial judgement of its attorneys as they look to achieve the best outcome for their clients in every case.
"With its intuitive usability and transparent prompting, Solve Intelligence makes the use of AI in the patent field easily accessible. The platform helps us evaluate large volumes of information efficiently and creates more room for what we do best: providing strategic advice to our clients." - Dr. Regina Neuefeind, Partner at Maiwald
Maiwald’s attorneys are now evaluating and using Solve Intelligence in selected use cases.
Prosecution, opposition and appeal. The platform summarises examiner objections, identifies the key grounds of rejection, and surfaces counterarguments and prosecution avenues for attorney review across EPO and German Patent Office practice, and into opposition and appeal, while the substantive decisions stay with the attorney.
Charts, built for the litigation team. Charts is where Solve supports the firm’s contentious practice. In one source-cited, auditable environment, Maiwald’s litigators and patent attorneys generate and analyse invalidity claim charts for nullity actions and EPO oppositions, conduct claim construction analyses, and evaluate search results.
Depth in life sciences. Life sciences and chemistry are among Maiwald’s defining strengths, and the platform is built for that type of work. Practitioners can create ChemDraw® structures and import and validate ST.26 sequence listings. Across dense prior-art domains like biologics, small molecules and diagnostics, the platform also gives claim-level visibility for portfolio reviews: mapping coverage against therapeutic areas, biosimilar entrants and competitor filings, and exposure across patent term and regulatory exclusivity.
Solve Assistant. Solve’s agentic Assistant, the newest module, is already in use, handling everyday, multi-step tasks from searching portfolios, drafting letters, and legal research.
This is a partnership with people behind it, not just a licence to software. Maiwald is supported on the ground by Solve’s Munich office and by a dedicated, German-speaking team matched to the firm’s practice areas: patent litigators and patent attorneys admitted before the Unified Patent Court, the German courts and the European Patent Office, with years of private-practice experience across the firm’s core fields, including life sciences.
Around 35% of Solve’s team are qualified patent attorneys and IP specialists, so Maiwald’s attorneys work with people who understand the craft and the forums they practise in. That same team leads the rollout, building custom AI styles and templates by team, client and jurisdiction, and Solve looks forward to continuing the partnership in person in Germany.
“This is a collaborative partnership. We are pleased to support Maiwald in selected AI-supported workflows for IP work , and Solve will continue to build the go-to AI platform for German and global patent practice.” - Dr. Lukas Wollenschlaeger from Solve Intelligence’s Munich office, previously a patent litigator at Hogan Lovells
Maiwald’s adoption of Solve isn’t about replacing what makes the firm exceptional. Its attorneys bring deep scientific training, decades of prosecution and litigation experience, and a record of securing and defending consequential patents.
What Solve does is take the mechanical work off their plate, so they can focus where their expertise decides outcomes: prosecution and opposition strategy, the analysis behind a dispute, portfolio positioning, and multi-jurisdictional filing and litigation across the EPO, the national courts and the UPC. For a firm that has spent decades defining excellent IP practice in Europe, that is exactly the right use of AI.
1 ChemDraw® is a registered trade mark of Revvity Signals Software, Inc.
.avif)
